Dupuytren, Ledderhose, and Peyronie Diseases after Primidone Use for Essential Tremor
Neurologist 24:150-151, Felipe, L.,et al, 2019
Lamotrigine: An Unusual Etiology for Aseptic Meningitis
Neurologist 16:35-36, Lam,G.,et al, 2010
Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004
Misdiagnosis of Epilepsy in Patients Prescribed Anticonvulsant Drugs for Other Reasons
BMJ 326:326-327, Oto,M.,et al, 2003
Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003
Dysgeusia in Epileptic Patients Treated with Lamotrigine: Report of Three Cases
Neurol 57:1521, Avoni,P.,et al, 2001
Uveal Effusion and Secondary Angle-Closure Glaucoma Associated with Topiramate Use
Arch Ophthalmol 119:1210-1211, Sankar,P.S., 2001
Gabapentin-Induced Anorgasmia
Neurol 53:2209, Clark,J.D.&Elliott,J., 1999
Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997
Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996
Reversible Dementia and Apparent Brain Atrophy During Valproate Therapy
Ann Neurol 38:687-691, Papazian,O.,et al, 1995
Seizure Exacerbation and Status Epilepticus Related to Carbamazepine-10, 11-Epoxide
Ann Neurol 35:743-746, So,E.L.,et al, 1994
Choreiform Movements Associated with the Use of Valproate
Arch Neurol 51:702-704, Lancman,M.E.,et al, 1994
The Evaluation and Treatment of Seizures
NEJM 323:1468-1474, Scheuer,M.L.&Pedley,T.A., 1990
Carbamazepine Update
Editorial, Lancet 2:595-5971989., , 1989
Drug-Induced Seizures:A 10-Year Experience
Neurol 34:1582-1586, Messing,R.O.,et al, 1984
A 54-Year-Old Woman with Progressive Headache and Neurologic Decline
Neurol 102:e209190, Cheng,Y. & Zachariah,J., 2024
Forensic Neurology:Practice Considerations and Training Opportunities
Neurol 103:e209560, Zheng,D.,et al, 2024
Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary
Neurol 98:31-43, Price, R.,et al, 2022
The SANAD II study of the Effectiveness and Cost-Effectiveness of Levetiracetam, Zonisamide, or Lamotrigine for Newly Diagnosed Focal Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1363-1374, Marson, A.,et al, 2021
The SANAD II Study of the Effectiveness and Cost-Effectiveness of Valproate Versus Levetiracetam for Newly Diagnosed Generalised and Unclassifiable Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1375-1386, Marson, A.,et al, 2021
Initial Management of Seizure in Adults
NEJM 385:251-263, Smith, P.E.M., 2021
Deprescribing in Epilepsy
JAMA Neurol 77:673-674, Terman, S.W.,et al, 2020
Choosing Anticonvulsant Medications to Manage Status Epilepticus
NEJM 382:2569-2572, Wu, K., 2020
FDA Approves Fenfluramine for Treatment of Seizures Associated with Dravet Syndrome
FDA June2020, , 2020
Changes in Seizure Frequency and Antiepileptic Therapy during Pregnancy
NEJM 383:2547-2556, Pennell, P.G.,et al, 2020
Efficacy and Safety of Adjunctive Lacosamide in the Treatment of Primary Generalised Tonic-Clonic Seizures: A Double-Blind, Randomised, Placebo-Controlled Trial
JNNP 91:1067-1075, Vossler, D.G.,et al, 2020
Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs with Risk for Attention-Deficit/Hyperactivity Disorder in Offspring
JAMA Netw Open 2:e186606, Christensen, J.,et al, 2019
Hemophagocytic Lymphohistiocytosis Associated with the Use of Lamotrigine
Neurol 92:e2401-e2405, Kim, T.,et al, 2019
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Risk of 23 Specific Malformations Associated with Prenatal Exposure to 10 Antiepileptic Drugs
Neurol 93:e167-e180, Blotiere, P.O.,et al, 2019
Declining Malformation Rates with Changed Antiepileptic Drug Prescribing, An Observational Study
Neurol 93:e831-e840, Tomson,T.,et al, 2019
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
NEJM 381:2103-2113,2171, Kapur, J.,et al, 2019
Efficacy and Tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy
Neurol 91:82-90, Kanner, A.M.,et al, 2018
Efficacy and Tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy
Neurol 91:74-81, Kanner, A.M.,et al, 2018
Antiepileptic Drug Treatment After An Unprovoked First Seizure
Neurol 91:e1429-e1439,684, Bao, E.L.,et al, 2018
Switching the Manufacturer of Antiepileptic Drugs is Associated with Higher Risk of Seizures: A Nationwide Study of Prescription Data in Germany
Ann Neurol 84:918-925, Lang, J.D.,et al, 2018
Neurological Autoantibody Prevalence in Epilepsy on Unknown Etiology
JAMA Neurol 74:397-402,384, Dubey, D.,et al, 2017
Maternal Use of antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children
JAMA 318:1700-1701, Bromley, R.L.,et al, 2017
Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
Powassan Virus-A New Reemerging Tick-Borne Disease
Front Public Health 5:342, Fatmi,S.S., et al, 2017
Orthostatic Tremor
Neurol 86:458-464, Hassan, A.,et al, 2016
Diabetic Sensory and Motor Neuropathy
NEJM 374:1455-1464, Vinik, A.I.,et al, 2016
Antiseizure Medications
Neurol 86:e187-e188, Karceski, S., 2016
Lamotrigine Use in Pregnancy and Risk of Orofacial Cleft and Other Congenital Anomalies
Neurol 86:1716-1725, Dolk, H.,et al, 2016
Prophylactic Antiepileptics and Seizure Incidence Following Subarachnoid Hemorrhage
Stroke 47:1754-1760, Panczykowski, D.,et al, 2016
Treatment of Brain Metastases
J Clin Oncol 33:3475-3484, Lin, X. & DeAngelis, L.M., 2015
Fibromyalgia
BMJ 345:g1224, Rahman, A.,et al, 2014
Drug Treatment of Epilepsy in Adults
BMJ 348:g2546, Schmidt, D. & Schachter, S.C., 2014